Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies.

scientific article published on March 1994

Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0889-8529(18)30113-0
P698PubMed publication ID7913026

P2093author name stringMallette LE
P2860cites workMitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1Q69919207
Familial hyperparathyroidismQ70019389
Divergent influences of calcium ions on releasing factor-stimulated anterior pituitary hormone secretion in normal manQ70480426
Comparison between the plasma concentrations of prolactin and parathyroid hormone in normal subjects and in patients with hyperparathyroidism or hyperprolactinemiaQ70483391
Fibroosseous tumors of the facial skeleton in association with primary hyperparathyroidism: An endocrine syndrome or coincidence?Q70931998
The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindredsQ71012104
Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid explorationQ71136820
Familial hyperparathyroidismQ71204770
High-resolution parathyroid ultrasonography in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)Q71305308
Familial hypocalciuric hypercalcemiaQ71310419
Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantationQ71349807
Autosomal recessive inheritance of familial hyperparathyroidismQ71836806
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1Q28257084
Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemiaQ35829417
AUTO- AND ISOTRANSPLANTATION, IN DOGS, OF THE PARATHYROID GLANDULES.Q36241108
Parathyroid carcinoma in familial hyperparathyroidismQ36614621
Multiple endocrine adenomatosis (Type I) and familial hyperparathyroidismQ36714712
The parathyroid polyhormones: new concepts in the spectrum of peptide hormone actionQ37779800
The role of parathyroid ultrasonography in the management of primary hyperparathyroidismQ38665643
Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I)Q39245542
Multiple endocrine neoplasia. Type IIa.Q39398470
Effect of Parathyroid Hormone on Plasma Prolactin in ManQ40301398
Circulating Parathyroid Hormone Activity: Familial Hypocalciuric Hypercalcemia Versus Typical Primary Hyperparathyroidism*Q40301596
Surgical resection of metastatic parathyroid carcinomaQ40350265
Relationship of Free and Total Calcium in Hypercalcemic ConditionsQ41500216
The Undescended “Parathymus” An Occasional Cause of Failed Neck Exploration for HyperparathyroidismQ41722086
Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2aQ42445792
Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*Q42464524
Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease courseQ42514302
Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisalQ43448006
Parathyroid re-exploration. A clinical and pathological study of 112 casesQ44787118
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.Q45094261
Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemiaQ45280155
Studies on localization of calcitonin gene-related peptide (CGRP) in the thyroid-parathyroid complexQ46748351
Prolactin and Calcitonin Responses to Parathyroid Hormone Infusion in Hypoparathyroid, Pseudohypoparathyroid, and Normal Subjects*Q54531350
Jaw lesions in familial hyperparathyroidismQ56762308
Familial hyperparathyroidism associated with cementifying fibromas of the jaws in two siblingsQ61047265
Factors that influence the assessment of parathyroid graft functionQ63984956
Management of Parathyroid Glands in Surgery for Medullary Thyroid CarcinomaQ66930002
A Detailed Evaluation of Oral Phosphate Therapy in Selected Patients With Primary Hyperparathyroidism*Q67277725
Transcervical thymectomy: an integral part of neck exploration for hyperparathyroidismQ67442340
Replantation of cryopreserved human parathyroid tissueQ67818343
Secondary hyperparathyroidism: diagnosis of site of recurrenceQ67973053
Malignancy hypercalcemia: evaluation of parathyroid function and response to treatmentQ68025346
Cell kinetics in parathyroid adenomas: evidence for decline in rates of cell birth and tumour growth, assuming clonal originQ68033607
Resection of select mediastinal parathyroid adenomas through an anterior mediastinotomyQ68047114
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidismQ68073340
Parathyroid carcinoma in familial hyperparathyroidismQ68702842
Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2Q68729988
Familial cystic parathyroid adenomatosisQ69049670
Familial hyperparathyroidism in association with colonic carcinomaQ69053790
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conferenceQ69383028
Angiographic ablation of parathyroid adenomas: lessons from a 10-year experienceQ69456552
Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomyQ69858364
Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1Q69881030
Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1Q69893891
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experienceQ69912831
P433issue1
P921main subjecthyperparathyroidismQ1344835
multiple endocrine neoplasiaQ1553018
P304page(s)19-36
P577publication date1994-03-01
P1433published inEndocrinology and Metabolism Clinics of North AmericaQ15763298
P1476titleManagement of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies
P478volume23

Reverse relations

cites work (P2860)
Q41461077Clinical and molecular aspects of multiple endocrine neoplasia.
Q47267819Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia
Q73015245[Multiple endocrine neoplasia Type I. Diagnosis and therapy in a case with classical family history]

Search more.